News Releases News Releases Year None202220212020201920182016 August 4, 2022 NextCure Provides Business Update and Reports Second Quarter 2022 Financial Results July 6, 2022 NextCure Announces Development of a Highly Specific Immunohistochemical Diagnostic for Siglec-15-positive Tumors as reported in Laboratory Investigation June 27, 2022 NextCure Presented NC410 Data at the Extracellular Matrix (ECM) Pharmacology Congress in Europe on Overcoming Clinical Limitations to Immunotherapy Through Remodeling Tumor ECM June 22, 2022 Dr. Brahm Segal appointed to NextCure Scientific Advisory Board; NextCure and Roswell Park Shared Nonclinical Data on the Impact of NC410 Blockade on Neutrophil-mediated T Cell Suppression at the 24th Translational Research Cancer Centers Consortium Annua June 8, 2022 NextCure to Present at the JMP Securities Life Sciences Conference May 5, 2022 NextCure Provides Business Update and Reports First Quarter 2022 Financial Results May 3, 2022 NextCure to Present at the BofA Securities 2022 Healthcare Conference April 19, 2022 NextCure and the National Cancer Institute Announce Preclinical Data in Journal of Clinical Investigation April 5, 2022 NextCure to Present at 21st Annual Needham Virtual Healthcare Conference March 3, 2022 NextCure Provides Business Update and Reports Fourth Quarter and Full Year 2021 Financial Results Pagination Current page 1 Page 2 Next page next › Last page last » Displaying 1 - 10 of 11 Tools
News Releases Year None202220212020201920182016 August 4, 2022 NextCure Provides Business Update and Reports Second Quarter 2022 Financial Results July 6, 2022 NextCure Announces Development of a Highly Specific Immunohistochemical Diagnostic for Siglec-15-positive Tumors as reported in Laboratory Investigation June 27, 2022 NextCure Presented NC410 Data at the Extracellular Matrix (ECM) Pharmacology Congress in Europe on Overcoming Clinical Limitations to Immunotherapy Through Remodeling Tumor ECM June 22, 2022 Dr. Brahm Segal appointed to NextCure Scientific Advisory Board; NextCure and Roswell Park Shared Nonclinical Data on the Impact of NC410 Blockade on Neutrophil-mediated T Cell Suppression at the 24th Translational Research Cancer Centers Consortium Annua June 8, 2022 NextCure to Present at the JMP Securities Life Sciences Conference May 5, 2022 NextCure Provides Business Update and Reports First Quarter 2022 Financial Results May 3, 2022 NextCure to Present at the BofA Securities 2022 Healthcare Conference April 19, 2022 NextCure and the National Cancer Institute Announce Preclinical Data in Journal of Clinical Investigation April 5, 2022 NextCure to Present at 21st Annual Needham Virtual Healthcare Conference March 3, 2022 NextCure Provides Business Update and Reports Fourth Quarter and Full Year 2021 Financial Results Pagination Current page 1 Page 2 Next page next › Last page last » Displaying 1 - 10 of 11